United Therapeutics | UTHR - Loan Capital


United Therapeutics reported $100M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Ardelyx USD 202.14M 27.07M Sep/2025
Baxter International USD 9.47B 726M Dec/2025
Bayer EUR 31.83B 877M Dec/2025
BioCryst Pharmaceuticals USD 428.67M 234.31M Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Insmed USD 540.96M 1.24M Dec/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
J&J USD 39.44B 30M Dec/2025
Lexicon Pharmaceuticals USD 49.41M 7.1M Dec/2025
Moderna USD 610M 584M Dec/2025
Omeros USD 403.72M 27.2M Jun/2024
Pfizer USD 57.41B 93M Sep/2025
PTC Therapeutics USD 2.03B 193.22M Dec/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025